Kathy J. Helzlsouer - Publications

Affiliations: 
Johns Hopkins University, Baltimore, MD 
Area:
Epidemiology, Obstetrics and Gynecology

223 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Ghoneim DH, Zhu J, Zheng W, Long J, Murff HJ, Ye F, Setiawan VW, Wilkens LR, Khankari NK, Haycock P, Antwi SO, Yang Y, Arslan AA, Beane Freeman LE, Bracci PM, ... ... Helzlsouer KJ, et al. Mendelian randomization analysis of n-6 polyunsaturated fatty acid levels and pancreatic cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 32967863 DOI: 10.1158/1055-9965.EPI-20-0651  0.477
2020 Gallicchio L, Elena JW, Fagan S, Carter M, Hamilton AS, Hastert TA, Hunter LL, Li J, Lynch CF, Milam J, Millar MM, Modjeski D, Paddock LE, Reed AR, Moses LB, ... ... Helzlsouer KJ, et al. Utilizing SEER cancer registries for population-based cancer survivor epidemiologic studies: a feasibility study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 32651214 DOI: 10.1158/1055-9965.Epi-20-0153  0.403
2020 Zhong J, Jermusyk A, Wu L, Hoskins JW, Collins I, Mocci E, Zhang M, Song L, Chung CC, Zhang T, Xiao W, Albanes D, Andreotti G, Arslan AA, Babic A, ... ... Helzlsouer KJ, et al. A Transcriptome-Wide Association Study (TWAS) Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer. Journal of the National Cancer Institute. PMID 31917448 DOI: 10.1093/Jnci/Djz246  0.491
2019 Klein WMP, Jacobsen PB, Helzlsouer KJ. Alcohol and Cancer Risk: Clinical and Research Implications. Jama. PMID 31834355 DOI: 10.1001/Jama.2019.19133  0.342
2018 Walsh N, Zhang H, Hyland PL, Yang Q, Mocci E, Zhang M, Childs EJ, Collins I, Wang Z, Arslan AA, Beane-Freeman L, Bracci PM, Brennan P, Canzian F, Duell EJ, ... ... Helzlsouer KJ, et al. Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer. Journal of the National Cancer Institute. PMID 30541042 DOI: 10.1093/Jnci/Djy155  0.548
2018 Travis RC, Perez-Cornago A, Appleby PN, Albanes D, Joshu CE, Lutsey PL, Mondul AM, Platz EA, Weinstein SJ, Layne TM, Helzlsouer KJ, Visvanathan K, Palli D, Peeters PH, Bueno-de-Mesquita B, et al. A collaborative analysis of individual participant data from 19 prospective studies assesses circulating vitamin D and prostate cancer risk. Cancer Research. PMID 30425058 DOI: 10.1158/0008-5472.Can-18-2318  0.384
2018 Helzlsouer KJ. Can Less Be More for Individuals With Low-Risk Breast Cancer? Journal of the National Cancer Institute. PMID 30239849 DOI: 10.1093/Jnci/Djy129  0.445
2018 Klein AP, Wolpin BM, Risch HA, Stolzenberg-Solomon RZ, Mocci E, Zhang M, Canzian F, Childs EJ, Hoskins JW, Jermusyk A, Zhong J, Chen F, Albanes D, Andreotti G, Arslan AA, ... ... Helzlsouer KJ, et al. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Nature Communications. 9: 556. PMID 29422604 DOI: 10.1038/S41467-018-02942-5  0.491
2017 Klassen AC, Smith KC, Shuster M, Coa KI, Caulfield LE, Helzlsouer KJ, Peairs KS, Shockney LD, Stoney D, Hannum S. "We're Just Not Prepared for Eating Over Our Whole Life": A Mixed Methods Approach to Understanding Dietary Behaviors Among Longer Term Cancer Survivors. Integrative Cancer Therapies. 1534735417731515. PMID 28971702 DOI: 10.1177/1534735417731515  0.36
2017 Jung S, Allen N, Arslan AA, Baglietto L, Barricarte A, Brinton LA, Egleston BL, Falk RT, Fortner RT, Helzlsouer KJ, Gao Y, Idahl A, Kaaks R, Krogh V, Merritt MA, et al. Anti-Müllerian Hormone and risk of ovarian cancer in nine cohorts. International Journal of Cancer. PMID 28921520 DOI: 10.1002/Ijc.31058  0.444
2017 Petimar J, Wilson KM, Wu K, Wang M, Albanes D, van den Brandt PA, Cook MB, Giles GG, Giovannucci EL, Goodman GG, Goodman PJ, Håkansson N, Helzlsouer K, Key TJ, Kolonel LN, et al. A Pooled Analysis of 15 Prospective Cohort Studies on the Association Between Fruit, Vegetable, and Mature Bean Consumption and Risk of Prostate Cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 28446545 DOI: 10.1158/1055-9965.Epi-16-1006  0.389
2017 Ose J, Poole EM, Schock H, Lehtinen M, Arslan AA, Zeleniuch-Jacquotte A, Visvanathan K, Helzlsouer KJ, Buring JE, Lee IM, Tjønneland A, Dossus L, Trichopoulou A, Masala G, Onland-Moret NC, et al. Androgens are differentially associated with ovarian cancer subtypes in the Ovarian Cancer Cohort Consortium. Cancer Research. PMID 28381542 DOI: 10.1158/0008-5472.Can-16-3322  0.428
2017 Ose J, Schock H, Poole EM, Lehtinen M, Visvanathan K, Helzlsouer K, Buring JE, Lee IM, Tjønneland A, Boutron-Ruault MC, Trichopoulou A, Mattiello A, Onland-Moret NC, Weiderpass E, Sánchez MJ, et al. Pre-diagnosis insulin-like growth factor-I and risk of epithelial invasive ovarian cancer by histological subtypes: A collaborative re-analysis from the Ovarian Cancer Cohort Consortium. Cancer Causes & Control : Ccc. PMID 28205047 DOI: 10.1007/S10552-017-0852-8  0.353
2017 Gallicchio L, Calhoun C, Helzlsouer KJ. Hair loss associated with aromatase inhibitor treatment among breast cancer patients. Journal of Clinical Oncology. 35: e21619-e21619. DOI: 10.1200/Jco.2017.35.15_Suppl.E21619  0.364
2016 Gallicchio L, Calhoun C, Riseberg D, Helzlsouer K. Cardiovascular Health among Black and White Breast Cancer Patients Initiating Aromatase Inhibitor Therapy. The Breast Journal. PMID 27779346 DOI: 10.1111/Tbj.12709  0.403
2016 Zhang M, Wang Z, Obazee O, Jia J, Childs EJ, Hoskins J, Figlioli G, Mocci E, Collins I, Chung CC, Hautman C, Arslan AA, Beane-Freeman L, Bracci PM, Buring J, ... ... Helzlsouer KJ, et al. Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21. Oncotarget. PMID 27579533 DOI: 10.18632/Oncotarget.11041  0.55
2016 Gallicchio L, Calhoun C, Helzlsouer K. Effect of Aromatase Inhibitor Therapy on the Cardiovascular Health of Black and White Breast Cancer Patients. Clinical Breast Cancer. PMID 26943989 DOI: 10.1016/J.Clbc.2016.02.011  0.344
2016 Travis RC, Appleby PN, Martin RM, Holly JM, Albanes D, Black A, Bueno-de-Mesquita HB, Chan JM, Chen C, Chirlaque MD, Cook MB, Deschasaux M, Donovan JL, Ferrucci L, Galan P, ... ... Helzlsouer KJ, et al. A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk. Cancer Research. 76: 2288-300. PMID 26921328 DOI: 10.1158/0008-5472.Can-15-1551  0.386
2016 Gallicchio L, Calhoun C, Helzlsouer K. Aromatase inhibitor-related side effects and associated treatment discontinuation. Journal of Clinical Oncology. 34: 10076-10076. DOI: 10.1200/Jco.2016.34.15_Suppl.10076  0.365
2015 Sampson JN, Wheeler WA, Yeager M, Panagiotou O, Wang Z, Berndt SI, Lan Q, Abnet CC, Amundadottir LT, Figueroa JD, Landi MT, Mirabello L, Savage SA, Taylor PR, Vivo ID, ... ... Helzlsouer K, et al. Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types. Journal of the National Cancer Institute. 107. PMID 26464424 DOI: 10.1093/Jnci/Djv279  0.567
2015 Key TJ, Appleby PN, Travis RC, Albanes D, Alberg AJ, Barricarte A, Black A, Boeing H, Bueno-de-Mesquita HB, Chan JM, Chen C, Cook MB, Donovan JL, Galan P, Gilbert R, ... ... Helzlsouer KJ, et al. Carotenoids, retinol, tocopherols, and prostate cancer risk: pooled analysis of 15 studies. The American Journal of Clinical Nutrition. 102: 1142-57. PMID 26447150 DOI: 10.3945/Ajcn.115.114306  0.396
2015 Genkinger JM, Kitahara CM, Bernstein L, Berrington de Gonzalez A, Brotzman M, Elena JW, Giles GG, Hartge P, Singh PN, Stolzenberg-Solomon RZ, Weiderpass E, Adami HO, Anderson KE, Beane-Freeman LE, Buring JE, ... ... Helzlsouer KJ, et al. Central adiposity, obesity during early adulthood, and pancreatic cancer mortality in a pooled analysis of cohort studies. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. PMID 26347100 DOI: 10.1093/Annonc/Mdv355  0.376
2015 Kakourou A, Koutsioumpa C, Lopez DS, Hoffman-Bolton J, Bradwin G, Rifai N, Helzlsouer KJ, Platz EA, Tsilidis KK. Interleukin-6 and risk of colorectal cancer: results from the CLUE II cohort and a meta-analysis of prospective studies. Cancer Causes & Control : Ccc. 26: 1449-60. PMID 26220152 DOI: 10.1007/S10552-015-0641-1  0.416
2015 Arem H, Yu K, Xiong X, Moy K, Freedman ND, Mayne ST, Albanes D, Amundadottir LT, Arslan AA, Austin M, Bamlet WR, Beane-Freeman L, Bracci P, Canzian F, Chanock SJ, ... ... Helzlsouer K, et al. Correction: Vitamin D Metabolic Pathway Genes and Pancreatic Cancer Risk. Plos One. 10: e0129983. PMID 26039095 DOI: 10.1371/Journal.Pone.0129983  0.373
2015 Arem H, Yu K, Xiong X, Moy K, Freedman ND, Mayne ST, Albanes D, Arslan AA, Austin M, Bamlet WR, Beane-Freeman L, Bracci P, Canzian F, Cotterchio M, Duell EJ, ... ... Helzlsouer K, et al. Vitamin D metabolic pathway genes and pancreatic cancer risk. Plos One. 10: e0117574. PMID 25799011 DOI: 10.1371/Journal.Pone.0117574  0.427
2015 Calhoun C, Helzlsouer KJ, Gallicchio L. Racial differences in depressive symptoms and self-rated health among breast cancer survivors on aromatase inhibitor therapy. Journal of Psychosocial Oncology. 33: 263-77. PMID 25751493 DOI: 10.1080/07347332.2015.1019661  0.384
2015 Coa KI, Smith KC, Klassen AC, Caulfield LE, Helzlsouer K, Peairs K, Shockney L. Capitalizing on the "teachable moment" to promote healthy dietary changes among cancer survivors: the perspectives of health care providers. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 23: 679-86. PMID 25160494 DOI: 10.1007/S00520-014-2412-Z  0.356
2015 Olufade T, Gallicchio L, MacDonald R, Helzlsouer KJ. Musculoskeletal pain and health-related quality of life among breast cancer patients treated with aromatase inhibitors. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 23: 447-55. PMID 25128067 DOI: 10.1007/S00520-014-2364-3  0.738
2015 Helzlsouer KJ, Appling S, Scarvalone S, Manocheh S, Gallicchio L, MacDonald R, Henninger D, Varanasi A. The Technology Enhanced Navigation (TEN) Trial among low-income patients with breast cancer. Journal of Clinical Oncology. 33: 6500-6500. DOI: 10.1200/Jco.2015.33.15_Suppl.6500  0.389
2014 Lopez DS, Peskoe SB, Tsilidis KK, Hoffman-Bolton J, Helzlsouer KJ, Isaacs WB, Smith MW, Platz EA. Association of variants in genes related to the immune response and obesity with BPH in CLUE II. Prostate Cancer and Prostatic Diseases. 17: 353-8. PMID 25224558 DOI: 10.1038/Pcan.2014.36  0.335
2014 Hampras SS, Viscidi RP, Helzlsouer KJ, Lee JH, Fulp WJ, Giuliano AR, Platz EA, Rollison DE. Prospective study of seroreactivity to JC virus T-antigen and risk of colorectal cancers and adenomas. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 2591-6. PMID 25128403 DOI: 10.1158/1055-9965.Epi-14-0370  0.418
2014 Wolpin BM, Rizzato C, Kraft P, Kooperberg C, Petersen GM, Wang Z, Arslan AA, Beane-Freeman L, Bracci PM, Buring J, Canzian F, Duell EJ, Gallinger S, Giles GG, Goodman GE, ... ... Helzlsouer KJ, et al. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Nature Genetics. 46: 994-1000. PMID 25086665 DOI: 10.1038/Ng.3052  0.51
2014 Gallicchio L, Calhoun C, Helzlsouer KJ. Association between race and physical functioning limitations among breast cancer survivors. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 22: 1081-8. PMID 24292017 DOI: 10.1007/S00520-013-2066-2  0.404
2014 Gallicchio L, Calhoun C, Helzlsouer KJ. Abstract C33: Cardiovascular health among black and white breast cancer patients initiating aromatase inhibitor therapy Cancer Epidemiology, Biomarkers & Prevention. 23. DOI: 10.1158/1538-7755.Disp13-C33  0.452
2013 Gallicchio L, Calhoun C, Helzlsouer KJ. Aromatase inhibitor therapy and hair loss among breast cancer survivors. Breast Cancer Research and Treatment. 142: 435-43. PMID 24197658 DOI: 10.1007/S10549-013-2744-2  0.407
2013 Klein AP, Lindström S, Mendelsohn JB, Steplowski E, Arslan AA, Bueno-de-Mesquita HB, Fuchs CS, Gallinger S, Gross M, Helzlsouer K, Holly EA, Jacobs EJ, Lacroix A, Li D, Mandelson MT, et al. An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population. Plos One. 8: e72311. PMID 24058443 DOI: 10.1371/Journal.Pone.0072311  0.38
2013 Key TJ, Appleby PN, Reeves GK, Travis RC, Alberg AJ, Barricarte A, Berrino F, Krogh V, Sieri S, Brinton LA, Dorgan JF, Dossus L, Dowsett M, Eliassen AH, ... ... Helzlsouer KJ, et al. Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. The Lancet. Oncology. 14: 1009-19. PMID 23890780 DOI: 10.1016/S1470-2045(13)70301-2  0.365
2013 Gallicchio L, MacDonald R, Helzlsouer KJ. Insulin-like growth factor 1 and musculoskeletal pain among breast cancer patients on aromatase inhibitor therapy and women without a history of cancer. Journal of Cancer Research and Clinical Oncology. 139: 837-43. PMID 23408333 DOI: 10.1007/S00432-013-1391-7  0.372
2013 Jung S, Spiegelman D, Baglietto L, Bernstein L, Boggs DA, van den Brandt PA, Buring JE, Cerhan JR, Gaudet MM, Giles GG, Goodman G, Hakansson N, Hankinson SE, Helzlsouer K, Horn-Ross PL, et al. Fruit and vegetable intake and risk of breast cancer by hormone receptor status. Journal of the National Cancer Institute. 105: 219-36. PMID 23349252 DOI: 10.1093/Jnci/Djs635  0.466
2013 Elena JW, Steplowski E, Yu K, Hartge P, Tobias GS, Brotzman MJ, Chanock SJ, Stolzenberg-Solomon RZ, Arslan AA, Bueno-de-Mesquita HB, Helzlsouer K, Jacobs EJ, LaCroix A, Petersen G, Zheng W, et al. Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Cancer Causes & Control : Ccc. 24: 13-25. PMID 23112111 DOI: 10.1007/S10552-012-0078-8  0.387
2013 Helzlsouer KJ, Gallicchio L. Shedding light on serum vitamin D concentrations and the risk of rarer cancers. Anti-Cancer Agents in Medicinal Chemistry. 13: 65-9. PMID 23094922 DOI: 10.2174/1871520611307010065  0.442
2013 Alberg AJ, Jorgensen TJ, Ruczinski I, Wheless L, Shugart YY, Berthier-Schaad Y, Kessing B, Hoffman-Bolton J, Helzlsouer KJ, Kao WH, Francis L, Alani RM, Smith MW, Strickland PT. DNA repair gene variants in relation to overall cancer risk: a population-based study. Carcinogenesis. 34: 86-92. PMID 23027618 DOI: 10.1093/Carcin/Bgs304  0.489
2013 Helzlsouer KJ, Appling S, Scarvalone S, MacDonald R, Price A, Wolf B, Snyder I, Varanasi A. Abstract 1382: Overcoming disparities with technology-enhanced patient navigation: Implementation of a randomized controlled trial. Cancer Research. 73: 1382-1382. DOI: 10.1158/1538-7445.Am2013-1382  0.36
2013 Smith KC, Coa K, Klassen AC, Caulfield L, Shockney L, Helzlsouer KJ. Abstract 1356: Promoting dietary change in the care of long term cancer survivors: Perspectives of the clinical care team. Cancer Research. 73: 1356-1356. DOI: 10.1158/1538-7445.Am2013-1356  0.388
2012 Eliassen AH, Hendrickson SJ, Brinton LA, Buring JE, Campos H, Dai Q, Dorgan JF, Franke AA, Gao YT, Goodman MT, Hallmans G, Helzlsouer KJ, Hoffman-Bolton J, Hultén K, Sesso HD, et al. Circulating carotenoids and risk of breast cancer: pooled analysis of eight prospective studies. Journal of the National Cancer Institute. 104: 1905-16. PMID 23221879 DOI: 10.1093/Jnci/Djs461  0.469
2012 Jorgensen TJ, Ruczinski I, Yao Shugart Y, Wheless L, Berthier Schaad Y, Kessing B, Hoffman-Bolton J, Helzlsouer KJ, Kao WH, Francis L, Alani RM, Strickland PT, Smith MW, Alberg AJ. A population-based study of hedgehog pathway gene variants in relation to the dual risk of basal cell carcinoma plus another cancer. Cancer Epidemiology. 36: e288-93. PMID 22677152 DOI: 10.1016/J.Canep.2012.05.001  0.412
2012 Ruczinski I, Jorgensen TJ, Shugart YY, Schaad YB, Kessing B, Hoffman-Bolton J, Helzlsouer KJ, Kao WH, Wheless L, Francis L, Alani RM, Strickland PT, Smith MW, Alberg AJ. A population-based study of DNA repair gene variants in relation to non-melanoma skin cancer as a marker of a cancer-prone phenotype. Carcinogenesis. 33: 1692-8. PMID 22581838 DOI: 10.1093/Carcin/Bgs170  0.439
2012 Appling SE, Scarvalone S, MacDonald R, McBeth M, Helzlsouer KJ. Fatigue in breast cancer survivors: the impact of a mind-body medicine intervention. Oncology Nursing Forum. 39: 278-86. PMID 22543386 DOI: 10.1188/12.Onf.278-286  0.389
2012 Gallicchio L, MacDonald R, Wood B, Rushovich E, Fedarko NS, Helzlsouer KJ. Changes in bone biomarker concentrations and musculoskeletal symptoms among breast cancer patients initiating aromatase inhibitor therapy and women without a history of cancer. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 27: 1959-66. PMID 22508239 DOI: 10.1002/Jbmr.1641  0.396
2012 Zhang X, Spiegelman D, Baglietto L, Bernstein L, Boggs DA, van den Brandt PA, Buring JE, Gapstur SM, Giles GG, Giovannucci E, Goodman G, Hankinson SE, Helzlsouer KJ, Horn-Ross PL, Inoue M, et al. Carotenoid intakes and risk of breast cancer defined by estrogen receptor and progesterone receptor status: a pooled analysis of 18 prospective cohort studies. The American Journal of Clinical Nutrition. 95: 713-25. PMID 22277553 DOI: 10.3945/Ajcn.111.014415  0.397
2012 Forsythe LP, Helzlsouer KJ, MacDonald R, Gallicchio L. Daytime sleepiness and sleep duration in long-term cancer survivors and non-cancer controls: results from a registry-based survey study. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 20: 2425-32. PMID 22218738 DOI: 10.1007/S00520-011-1358-7  0.34
2012 Gallicchio L, MacDonald R, Wood B, Rushovich E, Helzlsouer KJ. Menopausal-type symptoms among breast cancer patients on aromatase inhibitor therapy Climacteric. 15: 339-349. PMID 22191462 DOI: 10.3109/13697137.2011.620658  0.403
2012 Yeh HC, Platz EA, Wang NY, Visvanathan K, Helzlsouer KJ, Brancati FL. A prospective study of the associations between treated diabetes and cancer outcomes. Diabetes Care. 35: 113-8. PMID 22100961 DOI: 10.2337/Dc11-0255  0.409
2012 Helzlsouer KJ, Gallicchio L, MacDonald R, Wood B, Rushovich E. A prospective study of aromatase inhibitor therapy, vitamin D, C-reactive protein and musculoskeletal symptoms. Breast Cancer Research and Treatment. 131: 277-85. PMID 21904883 DOI: 10.1007/S10549-011-1729-2  0.392
2012 Tung K, Viscidi RP, Helzlsouer KJ, Lee J, Fulp WJ, Giuliano AR, Platz EA, Rollison DE. Abstract 5490: Prospective study of seroreactivity to JC virus T-Antigen and risk of colorectal cancers and adenomas Cancer Research. 72: 5490-5490. DOI: 10.1158/1538-7445.Am2012-5490  0.399
2012 Gallicchio LM, Helzlsouer KJ. Abstract 3584: Cardiovascular risk factors and co-morbid conditions among African-American and Caucasian breast cancer survivors Cancer Research. 72: 3584-3584. DOI: 10.1158/1538-7445.Am2012-3584  0.473
2012 Ruczinski I, Jorgensen T, Shugart YY, Berthier-Schaad Y, Kessing B, Hoffman-Bolton J, Helzlsouer K, Kao WHL, Wheless L, Francis L, Alani R, Strickland P, Smith M, Alberg AJ. Abstract 2636: Nonmelanoma skin cancer as a marker of a cancer-prone phenotype: Potential role of DNA repair gene variants Cancer Research. 72: 2636-2636. DOI: 10.1158/1538-7445.Am2012-2636  0.46
2012 Papas M, Helzlsouer K, Caulfield L, Alberg A, Gary-Webb T. Adolescent Fast Food Intake in Relation to Obesity and Chronic Disease Risk Factors Annals of Epidemiology. 22: 674. DOI: 10.1016/J.Annepidem.2012.06.066  0.559
2011 Key TJ, Appleby PN, Reeves GK, Roddam AW, Helzlsouer KJ, Alberg AJ, Rollison DE, Dorgan JF, Brinton LA, Overvad K, Kaaks R, Trichopoulou A, Clavel-Chapelon F, Panico S, et al. Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. British Journal of Cancer. 105: 709-22. PMID 21772329 DOI: 10.1038/Bjc.2011.254  0.447
2011 Helzlsouer KJ. The numbers game: the risky business of projecting risk. Journal of the National Cancer Institute. 103: 992-3. PMID 21705680 DOI: 10.1093/Jnci/Djr222  0.387
2011 Oktay JS, Bellin MH, Scarvalone S, Appling S, Helzlsouer KJ. Managing the impact of posttreatment fatigue on the family: breast cancer survivors share their experiences. Families, Systems & Health : the Journal of Collaborative Family Healthcare. 29: 127-37. PMID 21688904 DOI: 10.1037/A0023947  0.359
2011 Gallicchio L, Macdonald R, Wood B, Rushovich E, Helzlsouer KJ. Androgens and musculoskeletal symptoms among breast cancer patients on aromatase inhibitor therapy. Breast Cancer Research and Treatment. 130: 569-77. PMID 21647676 DOI: 10.1007/S10549-011-1611-2  0.376
2010 Wolpin BM, Kraft P, Xu M, Steplowski E, Olsson ML, Arslan AA, Bueno-de-Mesquita HB, Gross M, Helzlsouer K, Jacobs EJ, LaCroix A, Petersen G, Stolzenberg-Solomon RZ, Zheng W, Albanes D, et al. Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 3140-9. PMID 20971884 DOI: 10.1158/1055-9965.Epi-10-0751  0.349
2010 Lai GY, Helzlsouer KJ, Clipp SL, Rifai N, Platz EA. Association between C-peptide concentration and prostate cancer incidence in the CLUE II cohort study. Cancer Prevention Research (Philadelphia, Pa.). 3: 1334-41. PMID 20858760 DOI: 10.1158/1940-6207.Capr-10-0053  0.367
2010 Lam TK, Ruczinski I, Helzlsouer KJ, Shugart YY, Caulfield LE, Alberg AJ. Cruciferous vegetable intake and lung cancer risk: a nested case-control study matched on cigarette smoking. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 2534-40. PMID 20841387 DOI: 10.1158/1055-9965.Epi-10-0475  0.385
2010 Helzlsouer KJ. Overview of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. American Journal of Epidemiology. 172: 4-9. PMID 20562193 DOI: 10.1093/Aje/Kwq119  0.399
2010 Abnet CC, Chen Y, Chow WH, Gao YT, Helzlsouer KJ, Le Marchand L, McCullough ML, Shikany JM, Virtamo J, Weinstein SJ, Xiang YB, Yu K, Zheng W, Albanes D, Arslan AA, et al. Circulating 25-hydroxyvitamin D and risk of esophageal and gastric cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. American Journal of Epidemiology. 172: 94-106. PMID 20562192 DOI: 10.1093/Aje/Kwq121  0.321
2010 Gallicchio L, Helzlsouer KJ, Chow WH, Freedman DM, Hankinson SE, Hartge P, Hartmuller V, Harvey C, Hayes RB, Horst RL, Koenig KL, Kolonel LN, Laden F, McCullough ML, Parisi D, et al. Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. American Journal of Epidemiology. 172: 10-20. PMID 20562188 DOI: 10.1093/Aje/Kwq116  0.386
2010 Gallicchio L, Moore LE, Stevens VL, Ahn J, Albanes D, Hartmuller V, Setiawan VW, Helzlsouer KJ, Yang G, Xiang YB, Shu XO, Snyder K, Weinstein SJ, Yu K, Zeleniuch-Jacquotte A, et al. Circulating 25-hydroxyvitamin D and risk of kidney cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. American Journal of Epidemiology. 172: 47-57. PMID 20562187 DOI: 10.1093/Aje/Kwq115  0.392
2010 Zheng W, Danforth KN, Tworoger SS, Goodman MT, Arslan AA, Patel AV, McCullough ML, Weinstein SJ, Kolonel LN, Purdue MP, Shu XO, Snyder K, Steplowski E, Visvanathan K, Yu K, ... ... Helzlsouer KJ, et al. Circulating 25-hydroxyvitamin D and risk of epithelial ovarian cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. American Journal of Epidemiology. 172: 70-80. PMID 20562186 DOI: 10.1093/Aje/Kwq118  0.398
2010 Stolzenberg-Solomon RZ, Jacobs EJ, Arslan AA, Qi D, Patel AV, Helzlsouer KJ, Weinstein SJ, McCullough ML, Purdue MP, Shu XO, Snyder K, Virtamo J, Wilkins LR, Yu K, Zeleniuch-Jacquotte A, et al. Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. American Journal of Epidemiology. 172: 81-93. PMID 20562185 DOI: 10.1093/Aje/Kwq120  0.4
2010 Purdue MP, Freedman DM, Gapstur SM, Helzlsouer KJ, Laden F, Lim U, Maskarinec G, Rothman N, Shu XO, Stevens VL, Zeleniuch-Jacquotte A, Albanes D, Bertrand K, Weinstein SJ, Yu K, et al. Circulating 25-hydroxyvitamin D and risk of non-hodgkin lymphoma: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. American Journal of Epidemiology. 172: 58-69. PMID 20562184 DOI: 10.1093/Aje/Kwq117  0.333
2010 Arslan AA, Helzlsouer KJ, Kooperberg C, Shu XO, Steplowski E, Bueno-de-Mesquita HB, Fuchs CS, Gross MD, Jacobs EJ, Lacroix AZ, Petersen GM, Stolzenberg-Solomon RZ, Zheng W, Albanes D, Amundadottir L, et al. Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Archives of Internal Medicine. 170: 791-802. PMID 20458087 DOI: 10.1001/Archinternmed.2010.63  0.403
2010 Michaud DS, Vrieling A, Jiao L, Mendelsohn JB, Steplowski E, Lynch SM, Wactawski-Wende J, Arslan AA, Bas Bueno-de-Mesquita H, Fuchs CS, Gross M, Helzlsouer K, Jacobs EJ, Lacroix A, Petersen G, et al. Alcohol intake and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium (PanScan). Cancer Causes & Control : Ccc. 21: 1213-25. PMID 20373013 DOI: 10.1007/S10552-010-9548-Z  0.365
2010 Wolpin BM, Kraft P, Gross M, Helzlsouer K, Bueno-de-Mesquita HB, Steplowski E, Stolzenberg-Solomon RZ, Arslan AA, Jacobs EJ, Lacroix A, Petersen G, Zheng W, Albanes D, Allen NE, Amundadottir L, et al. Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium. Cancer Research. 70: 1015-23. PMID 20103627 DOI: 10.1158/0008-5472.Can-09-2993  0.378
2010 Petersen GM, Amundadottir L, Fuchs CS, Kraft P, Stolzenberg-Solomon RZ, Jacobs KB, Arslan AA, Bueno-de-Mesquita HB, Gallinger S, Gross M, Helzlsouer K, Holly EA, Jacobs EJ, Klein AP, LaCroix A, et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nature Genetics. 42: 224-8. PMID 20101243 DOI: 10.1038/Ng.522  0.348
2010 Jacobs EJ, Chanock SJ, Fuchs CS, Lacroix A, McWilliams RR, Steplowski E, Stolzenberg-Solomon RZ, Arslan AA, Bueno-de-Mesquita HB, Gross M, Helzlsouer K, Petersen G, Zheng W, Agalliu I, Allen NE, et al. Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). International Journal of Cancer. Journal International Du Cancer. 127: 1421-8. PMID 20049842 DOI: 10.1002/Ijc.25148  0.456
2010 Mondul AM, Clipp SL, Helzlsouer KJ, Platz EA. Association between plasma total cholesterol concentration and incident prostate cancer in the CLUE II cohort. Cancer Causes & Control : Ccc. 21: 61-8. PMID 19806465 DOI: 10.1007/S10552-009-9434-8  0.364
2010 Torio CM, Klassen AC, Curriero FC, Caballero B, Helzlsouer K. The modifying effect of social class on the relationship between body mass index and breast cancer incidence. American Journal of Public Health. 100: 146-51. PMID 19150917 DOI: 10.2105/Ajph.2007.126979  0.414
2010 Gallicchio LM, MacDonald R, Wood B, Rushovich E, Helzlsouer K. Abstract B10: Side effects associated with aromatase inhibitor treatment among breast cancer patients Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-10-B10  0.406
2010 Eliassen AH, Hendrickson SJ, Dorgan JF, Hallmans G, Helzlsouer KJ, Sesso HD, Zeleniuch-Jacquotte A, Toniolo P, Dai Q, Goodman MT, Campos H, Hankinson SE. Abstract A90: Plasma carotenoids and risk of breast cancer: Pooled analysis of eight prospective cohorts Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-10-A90  0.478
2010 Helzlsouer KJ. Abstract PL04-05: Vitamin D: Panacea or a Pandora's box for prevention? Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-Pl04-05  0.363
2010 Helzlsouer KJ. Abstract CN02-03: Hopes and challenges for early detection of ovarian cancer Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-Cn02-03  0.371
2010 Purdue MP, Freedman DM, Gapstur SM, Helzlsouer KJ, Laden F, Lim U, Maskarinec G, Rothman N, Shu X, Stevens VL, Zeleniuch-Jacquotte A, Albanes D, Bertrand K, Weinstein SJ, Yu K, et al. Abstract 2805: A pooled investigation of circulating 25-hydroxyvitamin D and non-Hodgkin lymphoma: The Cohort Consortium Vitamin D Pooling Project of Rarer Cancers Cancer Research. 70: 2805-2805. DOI: 10.1158/1538-7445.Am10-2805  0.356
2010 Abnet CC, Chen Y, Chow W, Gao Y, Helzlsouer KJ, Marchand LL, McCullough ML, Shikany JM, Shu X. Abstract 2803: A pooled analysis of circulating 25(OH)D and upper gastrointestinal cancer risk in the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers Cancer Research. 70: 2803-2803. DOI: 10.1158/1538-7445.Am10-2803  0.439
2010 Gallicchio LM, Moore LE, Stevens VL, Ahn J, Albanes D, Hartmuller V, Setiawan VW, Helzlsouer KJ, Yang G, Xiang Y, Koenig K. Abstract 2800: The association between circulating 25-hydroxyvitamin D and the development of kidney cancer in the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers Cancer Research. 70: 2800-2800. DOI: 10.1158/1538-7445.Am10-2800  0.418
2010 Zeleniuch-Jacquotte A, Gallicchio L, Hartmuller V, Helzlsouer KJ, Horst R, McCullough ML, Setiawan VW, Shu X, Weinstein SJ, Hankinson SE. Abstract 2787: Circulating 25-hydroxyvitamin D and risk of endometrial cancer: Results from the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers Cancer Research. 70: 2787-2787. DOI: 10.1158/1538-7445.Am10-2787  0.387
2010 Danforth KN, Zheng W, Tworoger SS, Goodman MT, Arslan AA, Patel AV, McCullough ML, Weinstein SJ, Helzlsouer KJ. Abstract 2785: A pooled analysis of circulating 25(OH)D and ovarian cancer risk Cancer Research. 70: 2785-2785. DOI: 10.1158/1538-7445.Am10-2785  0.431
2010 McCullough ML, Weinstein SJ, Freedman DM, Helzlsouer K, Flanders WD, Albanes D, Ashby J, Chen Y, Bertrand K, Gallicchio L, Hankinson S, Hartge P, Hartmuller VW, Harvey N, Horst RL, et al. Abstract 2776: Correlates of circulating 25-hydroxyvitamin D among cancer free adults in the Cohort Consortium Vitamin D Pooling Project Cancer Research. 70: 2776-2776. DOI: 10.1158/1538-7445.Am10-2776  0.319
2010 Appling SE, MacDonald R, Scarvalone S, Gallicchio L, Helzlsouer K. Abstract A63: Effectiveness of a holistic mind-body intervention to treat fatigue in breast cancer survivors: Does race make a difference? Cancer Epidemiology, Biomarkers & Prevention. 19. DOI: 10.1158/1055-9965.Disp-10-A63  0.394
2010 Gallicchio L, Wood B, MacDonald R, Rushovich E, Helzlsouer K. Androgen Concentrations and Musculoskeletal Symptoms Among Breast Cancer Patients on Aromatase Inhibitor Therapy Annals of Epidemiology. 20: 693-694. DOI: 10.1016/J.Annepidem.2010.07.011  0.365
2009 Gallicchio L, Chang HH, Christo DK, Thuita L, Huang HY, Strickland P, Ruczinski I, Clipp S, Helzlsouer KJ. Single nucleotide polymorphisms in obesity-related genes and all-cause and cause-specific mortality: a prospective cohort study. Bmc Medical Genetics. 10: 103. PMID 19818126 DOI: 10.1186/1471-2350-10-103  0.747
2009 Tsilidis KK, Helzlsouer KJ, Smith MW, Grinberg V, Hoffman-Bolton J, Clipp SL, Visvanathan K, Platz EA. Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer Cancer Causes and Control. 20: 1739-1751. PMID 19760027 DOI: 10.1007/S10552-009-9427-7  0.372
2009 Chae YK, Huang HY, Strickland P, Hoffman SC, Helzlsouer K. Genetic polymorphisms of estrogen receptors α and β and the risk of developing prostate cancer Plos One. 4. PMID 19654868 DOI: 10.1371/Journal.Pone.0006523  0.409
2009 Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA, Bueno-de-Mesquita HB, Gross M, Helzlsouer K, Jacobs EJ, LaCroix A, Zheng W, Albanes D, Bamlet W, Berg CD, et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nature Genetics. 41: 986-90. PMID 19648918 DOI: 10.1038/Ng.429  0.436
2009 Kempen JH, Daniel E, Dunn JP, Foster CS, Gangaputra S, Hanish A, Helzlsouer KJ, Jabs DA, Kaçmaz RO, Levy-Clarke GA, Liesegang TL, Newcomb CW, Nussenblatt RB, Pujari SS, Rosenbaum JT, et al. Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study. Bmj (Clinical Research Ed.). 339: b2480. PMID 19578087 DOI: 10.1136/Bmj.B2480  0.322
2009 Lynch SM, Vrieling A, Lubin JH, Kraft P, Mendelsohn JB, Hartge P, Canzian F, Steplowski E, Arslan AA, Gross M, Helzlsouer K, Jacobs EJ, LaCroix A, Petersen G, Zheng W, et al. Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. American Journal of Epidemiology. 170: 403-13. PMID 19561064 DOI: 10.1093/Aje/Kwp134  0.317
2009 McSorley MA, Alberg AJ, Allen DS, Allen NE, Brinton LA, Dorgan JF, Kaaks R, Rinaldi S, Helzlsouer KJ. Prediagnostic circulating follicle stimulating hormone concentrations and ovarian cancer risk. International Journal of Cancer. Journal International Du Cancer. 125: 674-9. PMID 19444906 DOI: 10.1002/Ijc.24406  0.418
2009 Lam TK, Ruczinski I, Helzlsouer K, Shugart YY, Li KE, Clipp S, Strickland PT, Alberg AJ. Copy number variants of GSTM1 and GSTT1 in relation to lung cancer risk in a prospective cohort study. Annals of Epidemiology. 19: 546-52. PMID 19394866 DOI: 10.1016/J.Annepidem.2009.03.003  0.384
2009 Rollison DE, Helzlsouer KJ, Lee JH, Fulp W, Clipp S, Hoffman-Bolton JA, Giuliano AR, Platz EA, Viscidi RP. Prospective study of JC virus seroreactivity and the development of colorectal cancers and adenomas. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 1515-23. PMID 19383887 DOI: 10.1158/1055-9965.Epi-08-1119  0.404
2009 Wang MH, Helzlsouer KJ, Smith MW, Hoffman-Bolton JA, Clipp SL, Grinberg V, De Marzo AM, Isaacs WB, Drake CG, Shugart YY, Platz EA. Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II Prostate. 69: 874-885. PMID 19267370 DOI: 10.1002/Pros.20933  0.387
2009 Jorgensen TJ, Helzlsouer KJ, Clipp SC, Bolton JH, Crum RM, Visvanathan K. DNA repair gene variants associated with benign breast disease in high cancer risk women Cancer Epidemiology Biomarkers and Prevention. 18: 346-350. PMID 19124519 DOI: 10.1158/1055-9965.Epi-08-0659  0.463
2008 Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, Carter HB, Metter EJ, Chen C, Weiss NS, Fitzpatrick A, Hsing AW, Lacey JV, Helzlsouer K, Rinaldi S, Riboli E, et al. Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Annals of Internal Medicine. 149: 461-71, W83-8. PMID 18838726 DOI: 10.7326/0003-4819-149-7-200810070-00006  0.376
2008 Comstock GW, Alberg AJ, Huang HY, Wu K, Burke AE, Hoffman SC, Norkus EP, Gross M, Cutler RG, Morris JS, Spate VL, Helzlsouer KJ. The risk of developing lung cancer associated with antioxidants in the blood: ascorbic acids, carotenoids, alpha-tocopherol, selenium, and total peroxyl radical absorbing capacity. American Journal of Epidemiology. 168: 831-40. PMID 18820277 DOI: 10.1093/Aje/Kwn328  0.329
2008 Helzlsouer KJ. Dr. George W. Comstock--a primary care practitioner of public health. American Journal of Epidemiology. 168: 816-8. PMID 18794224 DOI: 10.1093/Aje/Kwn145  0.318
2008 Chen J, Ruczinski I, Jorgensen TJ, Yenokyan G, Yao Y, Alani R, Liégeois NJ, Hoffman SC, Hoffman-Bolton J, Strickland PT, Helzlsouer KJ, Alberg AJ. Nonmelanoma skin cancer and risk for subsequent malignancy. Journal of the National Cancer Institute. 100: 1215-22. PMID 18728282 DOI: 10.1093/Jnci/Djn260  0.395
2008 Gallicchio L, Kalesan B, Hoffman SC, Helzlsouer KJ. Non-cancer adverse health conditions and perceived health and function among cancer survivors participating in a community-based cohort study in Washington County, Maryland. Journal of Cancer Survivorship : Research and Practice. 2: 12-9. PMID 18648983 DOI: 10.1007/S11764-008-0046-1  0.373
2008 Tsilidis KK, Branchini C, Guallar E, Helzlsouer KJ, Erlinger TP, Platz EA. C-reactive protein and colorectal cancer risk: a systematic review of prospective studies. International Journal of Cancer. Journal International Du Cancer. 123: 1133-40. PMID 18528865 DOI: 10.1002/Ijc.23606  0.417
2008 Gallicchio L, Kalesan B, Huang HY, Strickland P, Hoffman SC, Helzlsouer KJ. Genetic polymorphisms of peroxisome proliferator-activated receptors and the risk of cardiovascular morbidity and mortality in a community-based cohort in washington county, Maryland. Ppar Research. 2008: 276581. PMID 18288282 DOI: 10.1155/2008/276581  0.364
2008 Gallicchio L, Chang H, Christo DK, Thuita L, Huang HY, Strickland P, Ruczinski I, Hoffman SC, Helzlsouer KJ. Single nucleotide polymorphisms in inflammation-related genes and mortality in a community-based cohort in Washington County, Maryland. American Journal of Epidemiology. 167: 807-13. PMID 18263601 DOI: 10.1093/Aje/Kwm378  0.751
2008 Tsilidis KK, Erlinger TP, Rifai N, Hoffman S, Hoffman-Bolton J, Helzlsouer KJ, Platz EA. C-reactive protein and colorectal adenoma in the CLUE II cohort. Cancer Causes & Control : Ccc. 19: 559-67. PMID 18214695 DOI: 10.1007/S10552-008-9117-X  0.313
2008 Sprenger A, Gross A, Axilbund J, Helzlsouer K, Armstrong D, May B, Visvanathan K. Abstract B25: Information on perceived breast cancer risk may help tailor risk assessment among high risk women Cancer Prevention Research. 1. DOI: 10.1158/1940-6207.Prev-08-B25  0.441
2008 Wood B, Gallicchio L, Kalesan B, Appling S, Rushovich E, Helzlsouer K. Abstract B20: Cognitive decline in breast cancer survivors associated with chemotherapy or aromatase inhibitor therapy Cancer Prevention Research. 1. DOI: 10.1158/1940-6207.Prev-08-B20  0.375
2008 Helzlsouer K, Gallicchio L, Wood B, Kalesan B, Appling S, Rushovich E, Fedarko N. Abstract B19: Aromatase inhibitor therapy, musculoskeletal symptoms and associations with vitamin D and C-reactive protein concentrations Cancer Prevention Research. 1. DOI: 10.1158/1940-6207.Prev-08-B19  0.337
2008 James M, Clipp S, Hoffman-Bolton J, Helzlsouer K, Visvanathan K. Abstract B145: Association between physical activity, sleep duration, and cancer risk among women in Washington County, MD: A prospective cohort study Cancer Prevention Research. 1. DOI: 10.1158/1940-6207.Prev-08-B145  0.44
2008 Jorgensen T, Helzlsouer K, Hoffman S, Hoffman-Bolton J, Crum R, Visvanathan K. Abstract A75: DNA repair genotypes associated with benign breast disease in women at high breast cancer risk Cancer Prevention Research. 1. DOI: 10.1158/1940-6207.Prev-08-A75  0.467
2007 Engel LS, Laden F, Andersen A, Strickland PT, Blair A, Needham LL, Barr DB, Wolff MS, Helzlsouer K, Hunter DJ, Lan Q, Cantor KP, Comstock GW, Brock JW, Bush D, et al. Polychlorinated biphenyl levels in peripheral blood and non-Hodgkin's lymphoma: a report from three cohorts. Cancer Research. 67: 5545-52. PMID 17545638 DOI: 10.1158/0008-5472.Can-06-3906  0.349
2007 Papas MA, Alberg AJ, Ewing R, Helzlsouer KJ, Gary TL, Klassen AC. The built environment and obesity. Epidemiologic Reviews. 29: 129-43. PMID 17533172 DOI: 10.1093/Epirev/Mxm009  0.584
2007 Visvanathan K, Santor D, Ali SZ, Brewster A, Arnold A, Armstrong DK, Davidson NE, Helzlsouer KJ. The reliability of nipple aspirate and ductal lavage in women at increased risk for breast cancer - A potential tool for breast cancer risk assessment and biomarker evaluation Cancer Epidemiology Biomarkers and Prevention. 16: 950-955. PMID 17507621 DOI: 10.1158/1055-9965.Epi-06-0974  0.425
2007 Rohrmann S, Genkinger JM, Burke A, Helzlsouer KJ, Comstock GW, Alberg AJ, Platz EA. Smoking and risk of fatal prostate cancer in a prospective U.S. study. Urology. 69: 721-5. PMID 17445658 DOI: 10.1016/J.Urology.2006.12.020  0.334
2007 Gallicchio L, McSorley MA, Newschaffer CJ, Huang HY, Thuita LW, Hoffman SC, Helzlsouer KJ. Body mass, polymorphisms in obesity-related genes, and the risk of developing breast cancer among women with benign breast disease. Cancer Detection and Prevention. 31: 95-101. PMID 17428620 DOI: 10.1016/J.Cdp.2007.02.004  0.445
2007 McSorley MA, Alberg AJ, Allen DS, Allen NE, Brinton LA, Dorgan JF, Pollak M, Tao Y, Helzlsouer KJ. C-reactive protein concentrations and subsequent ovarian cancer risk. Obstetrics and Gynecology. 109: 933-41. PMID 17400857 DOI: 10.1097/01.Aog.0000257126.68803.03  0.382
2007 Gallicchio L, Visvanathan K, Burke A, Hoffman SC, Helzlsouer KJ. Nonsteroidal anti-inflammatory drugs and the risk of developing breast cancer in a population-based prospective cohort study in Washington County, MD. International Journal of Cancer. Journal International Du Cancer. 121: 211-15. PMID 17330846 DOI: 10.1002/Ijc.22656  0.479
2007 Rohrmann S, Platz EA, Kavanaugh CJ, Thuita L, Hoffman SC, Helzlsouer KJ. Meat and dairy consumption and subsequent risk of prostate cancer in a US cohort study. Cancer Causes & Control : Ccc. 18: 41-50. PMID 17315319 DOI: 10.1007/S10552-006-0082-Y  0.38
2007 Visvanathan K, Crum RM, Strickland PT, You X, Ruczinski I, Berndt SI, Alberg AJ, Hoffman SC, Comstock GW, Bell DA, Helzlsouer KJ. Alcohol dehydrogenase genetic polymorphisms, low-to-moderate alcohol consumption, and risk of breast cancer. Alcoholism, Clinical and Experimental Research. 31: 467-76. PMID 17295732 DOI: 10.1111/J.1530-0277.2006.00334.X  0.545
2007 Berndt SI, Huang WY, Fallin MD, Helzlsouer KJ, Platz EA, Weissfeld JL, Church TR, Welch R, Chanock SJ, Hayes RB. Genetic variation in base excision repair genes and the prevalence of advanced colorectal adenoma. Cancer Research. 67: 1395-404. PMID 17283177 DOI: 10.1158/0008-5472.Can-06-1390  0.557
2007 Berndt SI, Platz EA, Fallin MD, Thuita LW, Hoffman SC, Helzlsouer KJ. Mismatch repair polymorphisms and the risk of colorectal cancer. International Journal of Cancer. Journal International Du Cancer. 120: 1548-54. PMID 17205513 DOI: 10.1002/Ijc.22510  0.602
2007 Alberg AJ, Kouzis A, Genkinger JM, Gallicchio L, Burke AE, Hoffman SC, Diener-West M, Helzlsouer KJ, Comstock GW. A prospective cohort study of bladder cancer risk in relation to active cigarette smoking and household exposure to secondhand cigarette smoke. American Journal of Epidemiology. 165: 660-6. PMID 17204516 DOI: 10.1093/Aje/Kwk047  0.362
2007 Jorgensen TJ, Visvanathan K, Ruczinski I, Thuita L, Hoffman S, Helzlsouer KJ. Breast cancer risk is not associated with polymorphic forms of xeroderma pigmentosum genes in a cohort of women from Washington County, Maryland Breast Cancer Research and Treatment. 101: 65-71. PMID 16823510 DOI: 10.1007/S10549-006-9263-3  0.485
2007 Helzlsouer KJ, Appling SE, Scarvalone S, McBeth M, Gallicchio L, Hoffman S. Inpact of a ten week mind-body medicine intervention on peristent fatigue following breast cancer treatment: 6 month follow- up Journal of Clinical Oncology. 25: 9062-9062. DOI: 10.1200/Jco.2007.25.18_Suppl.9062  0.393
2006 Rollison DE, Helzlsouer KJ, Pinney SM. Personal hair dye use and cancer: a systematic literature review and evaluation of exposure assessment in studies published since 1992. Journal of Toxicology and Environmental Health. Part B, Critical Reviews. 9: 413-39. PMID 17492526 DOI: 10.1080/10937400600681455  0.351
2006 Berndt SI, Platz EA, Fallin MD, Thuita LW, Hoffman SC, Helzlsouer KJ. Genetic variation in the nucleotide excision repair pathway and colorectal cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 2263-9. PMID 17119055 DOI: 10.1158/1055-9965.Epi-06-0449  0.6
2006 Gallicchio L, Berndt SI, McSorley MA, Newschaffer CJ, Thuita LW, Argani P, Hoffman SC, Helzlsouer KJ. Polymorphisms in estrogen-metabolizing and estrogen receptor genes and the risk of developing breast cancer among a cohort of women with benign breast disease. Bmc Cancer. 6: 173. PMID 16808847 DOI: 10.1186/1471-2407-6-173  0.565
2006 Gallicchio L, McSorley MA, Newschaffer CJ, Thuita LW, Argani P, Hoffman SC, Helzlsouer KJ. Flame-broiled food, NAT2 acetylator phenotype, and breast cancer risk among women with benign breast disease. Breast Cancer Research and Treatment. 99: 229-33. PMID 16541303 DOI: 10.1007/S10549-006-9203-2  0.415
2006 Rollison DE, Engels EA, Halsey NA, Shah KV, Viscidi RP, Helzlsouer KJ. Prediagnostic circulating antibodies to JC and BK human polyomaviruses and risk of non-Hodgkin lymphoma. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 543-50. PMID 16537714 DOI: 10.1158/1055-9965.Epi-05-0728  0.344
2006 Helzlsouer KJ, Erlinger TP, Platz EA. C-reactive protein levels and subsequent cancer outcomes: results from a prospective cohort study. European Journal of Cancer (Oxford, England : 1990). 42: 704-7. PMID 16513341 DOI: 10.1016/J.Ejca.2006.01.008  0.416
2006 Gallicchio L, McSorley MA, Newschaffer CJ, Thuita LW, Huang HY, Hoffman SC, Helzlsouer KJ. Nonsteroidal antiinflammatory drugs, cyclooxygenase polymorphisms, and the risk of developing breast carcinoma among women with benign breast disease. Cancer. 106: 1443-52. PMID 16502408 DOI: 10.1002/Cncr.21763  0.36
2006 Gallicchio L, Kouzis A, Genkinger JM, Burke AE, Hoffman SC, Diener-West M, Helzlsouer KJ, Comstock GW, Alberg AJ. Active cigarette smoking, household passive smoke exposure, and the risk of developing pancreatic cancer. Preventive Medicine. 42: 200-5. PMID 16458957 DOI: 10.1016/J.Ypmed.2005.12.014  0.371
2006 Genkinger JM, Platz EA, Hoffman SC, Strickland P, Huang HY, Comstock GW, Helzlsouer KJ. C47T polymorphism in manganese superoxide dismutase (MnSOD), antioxidant intake and survival. Mechanisms of Ageing and Development. 127: 371-7. PMID 16458347 DOI: 10.1016/J.Mad.2005.12.006  0.335
2006 Sato R, Helzlsouer KJ, Comstock GW, Hoffman SC, Norkus EP, Fried LP. A cross-sectional study of vitamin C and cognitive function in older adults: the differential effects of gender. The Journal of Nutrition, Health & Aging. 10: 37-44. PMID 16453056  0.454
2006 Kamangar F, Abnet CC, Hutchinson AA, Newschaffer CJ, Helzlsouer K, Shugart YY, Pietinen P, Dawsey SM, Albanes D, Virtamo J, Taylor PR. Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland). Cancer Causes & Control : Ccc. 17: 117-25. PMID 16411061 DOI: 10.1007/S10552-005-0439-7  0.329
2006 Brewster AM, Jorgensen TJ, Ruczinski I, Huang HY, Hoffman S, Thuita L, Newschaffer C, Lunn RM, Bell D, Helzlsouer KJ. Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): Relationship to breast cancer risk and familial predisposition to breast cancer Breast Cancer Research and Treatment. 95: 73-80. PMID 16319991 DOI: 10.1007/S10549-005-9045-3  0.477
2006 Rollison DE, Newschaffer CJ, Tao Y, Pollak M, Helzlsouer KJ. Premenopausal levels of circulating insulin-like growth factor I and the risk of postmenopausal breast cancer. International Journal of Cancer. Journal International Du Cancer. 118: 1279-84. PMID 16161053 DOI: 10.1002/Ijc.21471  0.437
2005 Visvanathan K, Santor D, Ali S, Brewster A, Arnold A, Armstrong D, Helzlsouer K. The reliability of ductal lavage in women at high risk for breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 1001. PMID 27944893 DOI: 10.1200/Jco.2005.23.16_Suppl.1001  0.43
2005 Rohrmann S, Paltoo DN, Platz EA, Hoffman SC, Comstock GW, Helzlsouer KJ. Association of vasectomy and prostate cancer among men in a Maryland cohort. Cancer Causes & Control : Ccc. 16: 1189-94. PMID 16215869 DOI: 10.1007/S10552-005-0304-8  0.349
2005 Rollison DE, Helzlsouer KJ, Halsey NA, Shah KV, Viscidi RP. Markers of past infection with simian virus 40 (SV40) and risk of incident non-Hodgkin lymphoma in a Maryland cohort. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 1448-52. PMID 15941954 DOI: 10.1158/1055-9965.Epi-04-0674  0.312
2005 Helzlsouer KJ. Contralateral prophylactic mastectomy: quantifying benefits and weighing the harms. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 4251-3. PMID 15795414 DOI: 10.1200/Jco.2005.12.904  0.436
2005 Brewster AM, Christo DK, Lai H, Helzlsouer K. Breast carcinoma chemoprevention in the community setting. Estimating risks and benefits. Cancer. 103: 1147-53. PMID 15674856 DOI: 10.1002/Cncr.20882  0.769
2005 Singh S, Platz EA, Armenian HK, Hoffman SC, Rifai N, Helzlsouer KJ. 227-S: Association Between Plasma C-Reactive Protein Concentration and Subsequent Breast Cancer American Journal of Epidemiology. 161. DOI: 10.1093/Aje/161.Supplement_1.S57B  0.384
2004 Genkinger JM, Platz EA, Hoffman SC, Comstock GW, Helzlsouer KJ. Fruit, vegetable, and antioxidant intake and all-cause, cancer, and cardiovascular disease mortality in a community-dwelling population in Washington County, Maryland. American Journal of Epidemiology. 160: 1223-33. PMID 15583375 DOI: 10.1093/Aje/Kwh339  0.396
2004 Friebel TM, Beutler RA, Lee SM, Bernhardt BA, Helzlsouer KJ, Griffin CA. Active recruitment increased enrollment in a hereditary cancer registry. Journal of Clinical Epidemiology. 57: 1172-6. PMID 15567634 DOI: 10.1016/J.Jclinepi.2004.04.007  0.451
2004 O'Brien TG, Guo Y, Visvanathan K, Sciulli J, McLaine M, Helzlsouer KJ, Watkins-Bruner D. Differences in ornithine decarboxylase and androgen receptor allele frequences among ethnic groups Molecular Carcinogenesis. 41: 120-123. PMID 15378650 DOI: 10.1002/Mc.20047  0.362
2004 Brewster AM, Alberg AJ, Strickland PT, Hoffman SC, Helzlsouer K. XPD polymorphism and risk of subsequent cancer in individuals with nonmelanoma skin cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 13: 1271-5. PMID 15298945  0.351
2004 Alberg AJ, Daudt A, Huang HY, Hoffman SC, Comstock GW, Helzlsouer KJ, Strickland PT, Bell DA. N-acetyltransferase 2 (NAT2) genotypes, cigarette smoking, and the risk of breast cancer. Cancer Detection and Prevention. 28: 187-93. PMID 15225898 DOI: 10.1016/J.Cdp.2004.04.001  0.407
2004 Erlinger TP, Muntner P, Helzlsouer KJ. WBC count and the risk of cancer mortality in a national sample of U.S. adults: results from the Second National Health and Nutrition Examination Survey mortality study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 13: 1052-6. PMID 15184263  0.336
2004 Platz EA, De Marzo AM, Erlinger TP, Rifai N, Visvanathan K, Hoffman SC, Helzlsouer KJ. No association between pre-diagnostic plasma C-reactive protein concentration and subsequent prostate cancer. The Prostate. 59: 393-400. PMID 15065087 DOI: 10.1002/Pros.10368  0.346
2004 Erlinger TP, Platz EA, Rifai N, Helzlsouer KJ. C-reactive protein and the risk of incident colorectal cancer. Jama. 291: 585-90. PMID 14762037 DOI: 10.1001/Jama.291.5.585  0.409
2004 Visvanathan K, Helzlsouer KJ, Boorman DW, Strickland PT, Hoffman SC, Comstock GW, O'Brien TG, Guo Y. Association among an ornithine decarboxylase polymorphism, androgen receptor gene (CAG) repeat length and prostate cancer risk. The Journal of Urology. 171: 652-5. PMID 14713779 DOI: 10.1097/01.Ju.0000108384.74718.73  0.356
2004 Rollison DE, Halsey NA, Shah KV, Vascidi RP, Helzlsouer KJ. A Population-Based Nested Case-Control Study of Prediagnostic Serum Antibodies to JC Virus and BK Virus and Risk of Non-Hodgkin’S Lymphoma. Blood. 104: 4552-4552. DOI: 10.1182/Blood.V104.11.4552.4552  0.319
2003 Key TJ, Appleby PN, Reeves GK, Roddam A, Dorgan JF, Longcope C, Stanczyk FZ, Stephenson HE, Falk RT, Miller R, Schatzkin A, Allen DS, Fentiman IS, Key TJ, Wang DY, ... ... Helzlsouer KJ, et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. Journal of the National Cancer Institute. 95: 1218-26. PMID 12928347 DOI: 10.1093/Jnci/Djg022  0.426
2003 Huang HY, Alberg AJ, Norkus EP, Hoffman SC, Comstock GW, Helzlsouer KJ. Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. American Journal of Epidemiology. 157: 335-44. PMID 12578804 DOI: 10.1093/Aje/Kwf210  0.392
2003 Cantor KP, Strickland PT, Brock JW, Bush D, Helzlsouer K, Needham LL, Zahm SH, Comstock GW, Rothman N. Risk of non-Hodgkin's lymphoma and prediagnostic serum organochlorines: beta-hexachlorocyclohexane, chlordane/heptachlor-related compounds, dieldrin, and hexachlorobenzene. Environmental Health Perspectives. 111: 179-83. PMID 12573902 DOI: 10.1289/Ehp.4347  0.337
2002 Platz EA, Helzlsouer KJ, Hoffman SC, Morris JS, Baskett CK, Comstock GW. Prediagnostic toenail cadmium and zinc and subsequent prostate cancer risk. The Prostate. 52: 288-96. PMID 12210489 DOI: 10.1002/Pros.10115  0.375
2002 Davidson NE, Helzlsouer KJ. Good news about oral contraceptives New England Journal of Medicine. 346: 2078-2079. PMID 12087145 DOI: 10.1056/Nejme020051  0.428
2002 Sato R, Helzlsouer KJ, Alberg AJ, Hoffman SC, Norkus EP, Comstock GW. Prospective study of carotenoids, tocopherols, and retinoid concentrations and the risk of breast cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 11: 451-7. PMID 12010859  0.581
2001 Egner PA, Wang JB, Zhu YR, Zhang BC, Wu Y, Zhang QN, Qian GS, Kuang SY, Gange SJ, Jacobson LP, Helzlsouer KJ, Bailey GS, Groopman JD, Kensler TW. Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer Proceedings of the National Academy of Sciences of the United States of America. 98: 14601-14606. PMID 11724948 DOI: 10.1073/Pnas.251536898  0.342
2001 Brewster A, Helzlsouer K. Breast cancer epidemiology, prevention, and early detection. Current Opinion in Oncology. 13: 420-5. PMID 11673680 DOI: 10.1097/00001622-200111000-00002  0.448
2001 Platz EA, Helzlsouer KJ. Selenium, zinc, and prostate cancer Epidemiologic Reviews. 23: 93-101. PMID 11588860 DOI: 10.1093/Oxfordjournals.Epirev.A000801  0.334
2001 Goodman JE, Lavigne JA, Wu K, Helzlsouer KJ, Strickland PT, Selhub J, Yager JD. COMT genotype, micronutrients in the folate metabolic pathway and breast cancer risk. Carcinogenesis. 22: 1661-5. PMID 11577006 DOI: 10.1093/Carcin/22.10.1661  0.469
2001 Laden F, Collman G, Iwamoto K, Alberg AJ, Berkowitz GS, Freudenheim JL, Hankinson SE, Helzlsouer KJ, Holford TR, Huang HY, Moysich KB, Tessari JD, Wolff MS, Zheng T, Hunter DJ. 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene and polychlorinated biphenyls and breast cancer: Combined analysis of five U.S. studies Journal of the National Cancer Institute. 93: 768-776. PMID 11353787 DOI: 10.1093/Jnci/93.10.768  0.489
2000 Goodman JE, Lavigne JA, Hengstler JG, Tanner B, Helzlsouer KJ, Yager JD. Catechol-O-methyltransferase polymorphism is not associated with ovarian cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 9: 1373-6. PMID 11142424  0.367
2000 Helzlsouer KJ, Huang HY, Alberg AJ, Hoffman S, Burke A, Norkus EP, Morris JS, Comstock GW. Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer. Journal of the National Cancer Institute. 92: 2018-23. PMID 11121464 DOI: 10.1093/Jnci/92.24.2018  0.326
2000 Alberg AJ, Singh S, May JW, Helzlsouer KJ. Epidemiology, prevention, and early detection of breast cancer. Current Opinion in Oncology. 12: 515-20. PMID 11085449 DOI: 10.1097/00001622-200011000-00001  0.335
2000 Newschaffer CJ, Helzlsouer KJ. Estrogen-progestin replacement and risk of breast cancer Journal of the American Medical Association. 284: 692-693; discussion . PMID 10927769  0.335
2000 Bazzano LA, Del Priore G, Lee MJ, Glaser AN, Harvey JA, Newschaffer CJ, Helzlsouer KJ, Roca CA, Schmidt PJ, Daly RC, Rubinow DR, Schairer C, Lubin J, Troisi R, Sturgeon S, et al. Estrogen-progestin replacement and risk of breast cancer [1] (multiple letters) Journal of the American Medical Association. 284: 691-694. PMID 10927765  0.333
2000 Alberg AJ, Gordon GB, Hoffman SC, Comstock GW, Helzlsouer KJ. Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and the subsequent risk of developing colon cancer Cancer Epidemiology Biomarkers and Prevention. 9: 517-521. PMID 10815698  0.36
2000 Gail MH, Costantino JP, Bryant J, Croyle R, Freedman L, Helzlsouer K, Vogel V. RESPONSE: re: weighing the risks and benefits of tamoxifen treatment for preventing breast cancer Journal of the National Cancer Institute. 92: 758-758. PMID 10793119 DOI: 10.1093/Jnci/92.9.758  0.428
2000 Tambor ES, Bernhardt BA, Geller G, Helzlsouer KJ, Doksum T, Holtzman NA. Should women at increased risk for breast and ovarian cancer be randomized to prophylactic surgery? An ethical and empirical assessment. Journal of Women's Health & Gender-Based Medicine. 9: 223-33. PMID 10787220 DOI: 10.1089/152460900318434  0.439
2000 Wu K, Helzlsouer KJ, Alberg AJ, Comstock GW, Norkus EP, Hoffman SC. A prospective study of plasma ascorbic acid concentrations and breast cancer (United States) Cancer Causes and Control. 11: 279-283. PMID 10782662 DOI: 10.1023/A:1008983718924  0.429
1999 Gail MH, Costantino JP, Bryant J, Croyle R, Freedman L, Helzlsouer K, Vogel V. Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer Journal of the National Cancer Institute. 91: 1829-1846. PMID 10547390 DOI: 10.1093/Jnci/91.21.1829  0.456
1999 Helzlsouer KJ. Bad news/good news: Information about breast cancer risk following prophylactic oophorectomy Journal of the National Cancer Institute. 91: 1442-1443. PMID 10469738 DOI: 10.1093/Jnci/91.17.1442  0.409
1999 Audrain J, Rimer B, Cella D, Stefanek M, Garber J, Pennanen M, Helzlsouer K, Vogel V, Lin TH, Lerman C. The impact of a brief coping skills intervention on adherence to breast self-examination among first-degree relatives of newly diagnosed breast cancer patients. Psycho-Oncology. 8: 220-9. PMID 10390734 DOI: 10.1002/(Sici)1099-1611(199905/06)8:3<220::Aid-Pon370>3.0.Co;2-C  0.443
1999 Helzlsouer KJ, Alberg AJ, Huang HY, Hoffman SC, Strickland PT, Brock JW, Burse VW, Needham LL, Bell DA, Lavigne JA, Yager JD, Comstock GW. Serum concentrations of organochlorine compounds and the subsequent development of breast cancer Cancer Epidemiology Biomarkers and Prevention. 8: 525-532. PMID 10385143  0.323
1999 Wu K, Helzlsouer KJ, Comstock GW, Hoffman SC, Nadeau MR, Selhub J. A prospective study on folate, B12, and pyridoxal 5'-phosphate (B6) and breast cancer Cancer Epidemiology Biomarkers and Prevention. 8: 209-217. PMID 10090298  0.343
1998 Alberg AJ, Visvanathan K, Helzlsouer KJ. Epidemiology, prevention, and early detection of breast cancer Current Opinion in Oncology. 10: 492-497. PMID 9818226  0.371
1998 Helzlsouer KJ, Huang HY, Strickland PT, Hoffman S, Alberg AJ, Comstock GW, Bell DA. Association between CYP17 polymorphisms and the development of breast cancer Cancer Epidemiology Biomarkers and Prevention. 7: 945-949. PMID 9796641  0.34
1998 Geller G, Bernhardt BA, Doksum T, Helzlsouer KJ, Wilcox P, Holtzman NA. Decision-making about breast cancer susceptibility testing: how similar are the attitudes of physicians, nurse practitioners, and at-risk women? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 16: 2868-76. PMID 9704741 DOI: 10.1200/Jco.1998.16.8.2868  0.382
1998 Santen RJ, Anderson T, Bardin CW, Barrett-Conner E, Black C, Borwhat M, Burger H, Clarkson T, Cobleigh M, Cosman F, Douglas MS, Dunaif A, Ford J, Ganz P, Gleason S, ... ... Helzlsouer K, et al. Treatment of estrogen deficiency symptoms in women surviving breast cancer Journal of Clinical Endocrinology and Metabolism. 83: 1993-2000. PMID 9626130 DOI: 10.1210/Jcem.83.6.4934  0.441
1998 Helzlsouer KJ, Selmin O, Huang HY, Strickland PT, Hoffman S, Alberg AJ, Watson M, Comstock GW, Bell D. Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer Journal of the National Cancer Institute. 90: 512-518. PMID 9539246 DOI: 10.1093/Jnci/90.7.512  0.492
1997 Lavigne JA, Helzlsouer KJ, Huang HY, Strickland PT, Bell DA, Selmin O, Watson MA, Hoffman S, Comstock GW, Yager JD. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer Cancer Research. 57: 5493-5497. PMID 9407957  0.38
1997 Alberg AJ, Helzlsouer KJ. Epidemiology, prevention, and early detection of breast cancer Current Opinion in Oncology. 9: 505-511. PMID 9370070 DOI: 10.1097/00001622-199911000-00003  0.344
1997 Rothman N, Cantor KP, Blair A, Bush D, Brock JW, Helzlsouer K, Zahm SH, Needham LL, Pearson GR, Hoover RN, Comstock GW, Strickland PT. A nested case-control study of non-Hodgkin lymphoma and serum organochlorine residues. Lancet. 350: 240-4. PMID 9242800 DOI: 10.1016/S0140-6736(97)02088-6  0.309
1997 Tangrea J, Helzlsouer K, Pietinen P, Taylor P, Hollis B, Virtamo J, Albanes D. Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes & Control : Ccc. 8: 615-25. PMID 9242478 DOI: 10.1023/A:1018450531136  0.371
1997 Whitmore SE, Anhalt GJ, Provost TT, Zacur HA, Hamper UM, Helzlsouer KJ, Rosenshein NB. Serum CA-125 screening for ovarian cancer in patients with dermatomyositis Gynecologic Oncology. 65: 241-244. PMID 9159332 DOI: 10.1006/Gyno.1997.4666  0.378
1996 Caplan LS, Helzlsouer KJ, Shapiro S, Wesley MN, Edwards BK. Reasons for delay in breast cancer diagnosis Preventive Medicine. 25: 218-224. PMID 8860288 DOI: 10.1006/Pmed.1996.0049  0.398
1996 Helzlsouer KJ, Alberg AJ, Norkus EP, Morris JS, Hoffman SC, Comstock GW. Prospective study of serum micronutrients and ovarian cancer. Journal of the National Cancer Institute. 88: 32-7. PMID 8847723 DOI: 10.1093/Jnci/88.1.32  0.352
1996 Helzlsouer KJ, Harris EL, Parshad R, Perry HR, Price FM, Sanford KK. DNA repair proficiency: potential susceptiblity factor for breast cancer. Journal of the National Cancer Institute. 88: 754-5. PMID 8637030 DOI: 10.1093/Jnci/88.11.754  0.372
1995 Helzlsouer KJ, Couzi R. Hormones and breast cancer Cancer. 76: 2059-2063. PMID 8635000 DOI: 10.1002/1097-0142(19951115)76:10+<2059::Aid-Cncr2820761325>3.0.Co;2-1  0.477
1995 Helzlsouer KJ, Gordon GB, Alberg AJ, Bush TL, Hoffman SC, Longcope C, Comstock GW. Serum Gonadotropins and Steroid Hormones and the Development of Ovarian Cancer Jama: the Journal of the American Medical Association. 274: 1926-1930. PMID 8568986 DOI: 10.1001/Jama.1995.03530240036037  0.392
1995 Kensler TW, Helzlsouer KJ. Oltipraz: clinical opportunities for cancer chemoprevention. p Journal of Cellular Biochemistry. Supplement. 22: 101-107. PMID 8538185 DOI: 10.1002/Jcb.240590813  0.304
1995 Braun MM, Helzlsouer KJ, Hollis BW, Comstock GW. Colon cancer and serum vitamin d metabolite levels 10-17 years prior to diagnosis American Journal of Epidemiology. 142: 608. PMID 7653469 DOI: 10.1093/Oxfordjournals.Aje.A117682  0.371
1995 Braun MM, Helzlsouer KJ, Hollis BW, Comstock GW. Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States) Cancer Causes and Control. 6: 235-239. PMID 7612803 DOI: 10.1007/Bf00051795  0.347
1995 Couzi RJ, Helzlsouer KJ, Fetting JH. Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy Journal of Clinical Oncology. 13: 2737-2744. PMID 7595732 DOI: 10.1200/Jco.1995.13.11.2737  0.401
1995 Caplan LS, Helzlsouer KJ, Shapiro S, Freedman LS, Coates RJ, Edwards BK. System delay in breast cancer in whites and blacks American Journal of Epidemiology. 142: 804-812. PMID 7572956 DOI: 10.1093/Oxfordjournals.Aje.A117719  0.373
1995 Stefanek ME, Helzlsouer KJ, Wilcox PM, Houn F. Predictors of and Satisfaction with Bilateral Prophylactic Mastectomy Preventive Medicine. 24: 412-419. PMID 7479633 DOI: 10.1006/Pmed.1995.1066  0.418
1995 BUSH TL, HELZLSOUER KJ. CON: The Role of Tamoxifen in Breast Cancer Treatment: Yes Prevention: No Journal of Women's Health. 4: 13-14. DOI: 10.1089/Jwh.1995.4.13  0.403
1994 Helzlsouer KJ, Ford DE, Hayward RSA, Midzenski M, Perry H. Perceived Risk of Cancer and Practice of Cancer Prevention Behaviors Among Employees in an Oncology Center Preventive Medicine. 23: 302-308. PMID 8078850 DOI: 10.1006/Pmed.1994.1042  0.455
1994 Helzlsouer KJ, Alberg AJ, Bush TL, Longcope C, Gordon GB, Comstock GW. A prospective study of endogenous hormones and breast cancer Cancer Detection and Prevention. 18: 79-85. PMID 8025899  0.309
1994 Helzlsouer KJ, Bush T. More on endometrial cancer and tamoxifen Journal of the National Cancer Institute. 86: 1877. PMID 7990165 DOI: 10.1093/Jnci/86.24.1877  0.42
1994 Ko WF, Helzlsouer KJ, Comstock GW. Serum albumin, bilirubin, and uric acid and the anatomic site-specific incidence of colon cancer Journal of the National Cancer Institute. 86: 1874-1875. PMID 7990163 DOI: 10.1093/Jnci/86.24.1874  0.334
1994 Weber BL, Watson P, Stefanek ME, Wells NL, Helzlsouer KJ. Case study: Mary is a healthy 33-year-old woman concerned about her risk of breast cancer Cancer Practice. 2: 252-255. PMID 7858651  0.32
1994 Helzlsouer KJ. Epidemiology, prevention, and early detection of breast cancer Current Opinion in Oncology. 6: 541-548. PMID 7827162 DOI: 10.1097/00001622-199411000-00002  0.474
1993 Helzlsouer KJ, Bush TL, Alberg AJ, Bass KM, Zacur H, Comstock GW. Prospective Study of Serum CA-125 Levels as Markers of Ovarian Cancer Jama: the Journal of the American Medical Association. 269: 1123-1126. PMID 8433467 DOI: 10.1001/Jama.1993.03500090059033  0.373
1993 Bush TL, Helzlsouer KJ. Tamoxifen for the primary prevention of breast cancer: A review and critique of the concept and trial Epidemiologic Reviews. 15: 233-243. PMID 8405207 DOI: 10.1093/Oxfordjournals.Epirev.A036110  0.382
1993 Helzlsouer KJ. Epidemiology, early detection, and prevention of breast cancer Current Opinion in Oncology. 5: 955-959. PMID 8305544 DOI: 10.1097/00001622-199311000-00002  0.448
1993 Helzlsouer KJ, Kensler TW. Cancer Chemoprotection by Oltipraz: Experimental and Clinical Considerations Preventive Medicine. 22: 783-795. PMID 8234218 DOI: 10.1006/Pmed.1993.1072  0.334
1993 Kensler T, Styczynski P, Groopman J, Helzlsouer K, Curphey T, Maxuitenko Y, Roebuck BD. Mechanisms of chemoprotection by oltipraz. Journal of Cellular Biochemistry. Supplement. 167-72. PMID 1305682 DOI: 10.1002/Jcb.240501331  0.331
1992 Comstock GW, Bush TL, Helzlsouer K. Serum retinol, beta-carotene, vitamin E, and selenium as related to subsequent cancer of specific sites. American Journal of Epidemiology. 135: 115-21. PMID 1536130 DOI: 10.1093/Oxfordjournals.Aje.A116264  0.353
1992 Helzlsouer KJ, Gordon GB, Alberg AJ, Bush TL, Comstock GW. Relationship of Prediagnostic Serum Levels of Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate to the Risk of Developing Premenopausal Breast Cancer Cancer Research. 52: 1-4. PMID 1530765  0.369
1991 Comstock GW, Helzlsouer KJ, Bush TL. Prediagnostic serum levels of carotenoids and vitamin E as related to subsequent cancer in Washington County, Maryland American Journal of Clinical Nutrition. 53. PMID 1985396 DOI: 10.1093/Ajcn/53.1.260S  0.42
1991 Gordon GB, Helzlsouer KJ, Comstock GW. Serum Levels of Dehydroepiandrosterone and Its Sulfate and the Risk of Developing Bladder Cancer Cancer Research. 51: 1366-1369. PMID 1825478  0.309
1990 Gordon GB, Helzlsouer KJ, Bush TL, Comstock GW, Miller SR. Relationship of Serum Levels of Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate to the Risk of Developing Postmenopausal Breast Cancer Cancer Research. 50: 3859-3862. PMID 2141293 DOI: 10.1016/0378-5122(91)90313-F  0.421
1985 Micozzi MS, Boone CW, Kelloff GJ, Tangrea JA, Helzlsouer KJ, Taylor PR. Chemoprevention of cancer: Implications for clinical pharmacology Journal of Clinical Pharmacology. 25: 164-175. PMID 3998196 DOI: 10.1002/J.1552-4604.1985.Tb02820.X  0.387
Show low-probability matches.